On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Understanding and Managing Migraine Patients
January 11th 2010Migraine headaches affect an estimated 25% to 30% of individuals in the United States. More than two thirds of patients who have migraines are women. Many women experience migraines before or during their menstrual cycle. Migraines can also run in families, and most often occur between 15 and 55 years of age.
Will Tablets, e-Readers, and Netbooks Bridge the Gap between Smartphones and Laptops?
The 2010 Consumer Electronics Show recently concluded in Las Vegas; but aside from everything transforming into 3D, there were some other advances and introductions in the world of tech gadgets that are worth mentioning.
"What We Need Now Is True Medical Care Reform," says Doctor in New Book - Time to Care
January 8th 2010"The current health care reform proposal is just a beginning," says Norman Makous, MD. "This legislation addresses health coverage reform. The problem that has not been touched in the current legislation relates to how we provide medical services.
New Thinking in Breakthrough Pain
January 7th 2010First identified in cancer patients in the 1970s, breakthrough pain is also a clinical challenge in other pain modalities, including neuropathy and back pain. With new information and more effective treatments now available, physicians are changing the way they approach this puzzle.
Biomedical Treatments for ASDs
Biomedical treatments for autism took another hit recently. A consensus report published in the January issue of Pediatrics takes Andrew Wakefield's ever popular "austistic enterocolitis" syndrome to task by reporting a lack of evidence that children with ASD have a higher incidence of digestive problems or that diet regimens (such as the highly publicized gluten-free and casein-free diet, or GFCF) are effective.
Maintenance Therapy Prolongs Disease Control in Metastatic Colorectal Cancer
January 5th 2010Patients with unresectable metastatic colorectal cancer who experience a chemotherapy-free interval (CFI) following first-line chemotherapy have shorter durations of disease control (DDC) and progression-free survival (PFS) compared with patients who begin maintenance therapy immediately, according to data from a French study.
A Combination of Imatinib Mesylate and Pegylate Interferon a2a in Chronic-phase CML
December 31st 2009The goal of this study is to determine whether the addition of the drug pegylated interferon-a2a in combination with imatinib mesylate will allow the imatinib to target and kill the leukemic stem cells, hopefully putting the leukemia in remission without the need for continuous treatment.
Study of Dasatinib in Patients with CML
December 31st 2009This clinical trial will assess the safety of dasatinib and whether this drug can help control CML in chronic phase. The study is split into two arms, with patients starting on a dosage of either 100 mg once daily or 50 mg twice daily of dasatinib.